The latest update is out from Australian Clinical Labs Ltd ( (AU:ACL) ).
Australian Clinical Labs Ltd has announced that First Sentier Investors RQI Pty Ltd, a subsidiary of Mitsubishi UFJ Financial Group, has become a substantial holder in the company as of April 7, 2025. This development signifies a notable shift in the ownership structure, potentially impacting the company’s strategic direction and stakeholder interests, as First Sentier Investors now holds significant voting power in the company.
More about Australian Clinical Labs Ltd
YTD Price Performance: -10.0%
Average Trading Volume: 921,933
Technical Sentiment Signal: Buy
Current Market Cap: A$566.4M
For detailed information about ACL stock, go to TipRanks’ Stock Analysis page.